House
RoundsGuidelinesCalculatorsPricing
Sign inCreate account→
House

Citation-backed clinical intelligence for verified physicians.

Product

  • Rounds
  • Guidelines
  • Calculators
  • Pricing

Company

  • About
  • Editorial Policy

© 2026 House

For verified, licensed physicians. Not a substitute for clinical judgement.

Back to guidelines
Cardiology · MOHFW

Hypertension in adults

MOHFW
B
Source:MoHFW Standard Treatment Guidelines — Hypertension (2021)India Hypertension Control Initiative (IHCI) Standard Treatment Workflow (2021)
Verified Apr 2026
Ask House about this guideline

Red Flags

  • BP ≥180/120 mmHg with chest pain, dyspnoea, neurological deficit, severe headache, or AKI — hypertensive emergency, immediate parenteral therapy[1]
  • BP ≥160/110 in pregnancy ≥20 weeks with proteinuria, severe headache, visual symptoms, or epigastric pain — preeclampsia/eclampsia[1]
  • Resistant hypertension (uncontrolled on 3 agents including a diuretic at maximally tolerated doses) — investigate secondary causes[1]
  • New BP ≥160/100 in a previously normotensive patient under 30 — secondary cause workup[1]

First-line treatment

Interventions

  • Lifestyle modification[1]
    Salt reduction <5 g/day, fruit-and-vegetable-rich diet, ≥150 minutes/week moderate aerobic activity, weight reduction if overweight, alcohol limitation, smoking cessation, stress management
  • Opportunistic screening[1]
    Measure BP at every healthcare contact in adults ≥18; targeted community screening for adults >50, diabetics, obese, family history of hypertension
  • Stepwise pharmacotherapy escalation[1]
    Start single agent for grade 1 HTN with low overall risk; dual therapy from outset for BP ≥160/100 or ≥20/10 above target; triple therapy if uncontrolled at 4–6 weeks

First-line drug therapy

DrugClassAdultPaediatricNotes
Amlodipine[1]Calcium channel blocker (DHP)5–10 mg PO once daily—First-line in IHCI primary-care workflow; widely available across PHCs and CHCs
Enalapril[1]ACE inhibitor5–40 mg PO daily, divided BD if higher dose—Alternative first-line; switch to ARB if cough develops
Telmisartan[1]Angiotensin receptor blocker (ARB)40–80 mg PO once daily—Preferred with diabetes, microalbuminuria, or chronic kidney disease
Hydrochlorothiazide[1]Thiazide diuretic12.5–25 mg PO once daily—Combination partner with CCB or ACE-i/ARB; cost-effective
Amlodipine[1]
Calcium channel blocker (DHP)
Adult
5–10 mg PO once daily
Paediatric
—
First-line in IHCI primary-care workflow; widely available across PHCs and CHCs
Enalapril[1]
ACE inhibitor
Adult
5–40 mg PO daily, divided BD if higher dose
Paediatric
—
Alternative first-line; switch to ARB if cough develops
Telmisartan[1]
Angiotensin receptor blocker (ARB)
Adult
40–80 mg PO once daily
Paediatric
—
Preferred with diabetes, microalbuminuria, or chronic kidney disease
Hydrochlorothiazide[1]
Thiazide diuretic
Adult
12.5–25 mg PO once daily
Paediatric
—
Combination partner with CCB or ACE-i/ARB; cost-effective

Safety-net

  1. Take medication every day even when feeling well — hypertension causes no symptoms until target organs are damaged[1]
  2. Sudden severe headache, chest pain, vision changes, slurred speech, or one-sided weakness — call emergency services immediately[1]
  3. Bring your BP record to every visit; home BP measurement helps confirm control between clinic visits[1]

Referral criteria

  • BP ≥180/120 mmHg with end-organ involvementEmergency department for parenteral antihypertensive and end-organ workup[1]
  • Resistant hypertension uncontrolled on 3 agents at maximally tolerated dosesCardiology or hypertension clinic for secondary cause workup[1]
  • Pregnancy with BP ≥140/90 mmHg, especially with proteinuria or symptomsObstetric medicine same-day[1]
  • Age <30 with new hypertension OR hypokalaemia OR abdominal bruitEndocrinology or nephrology for secondary cause workup[1]

Clinical summary

Primary-care management of hypertension per India's national Standard Treatment Guidelines, with opportunistic screening and stepwise pharmacotherapy.

References

  1. 1.MoHFW Standard Treatment Guidelines — Hypertension; India Hypertension Control Initiative (IHCI) Standard Treatment Workflow (2021)

On this page

  • Red flags
  • First-line treatment
  • Safety-net
  • Referral
  • References